In this research study, we plan to leverage our large fetal normative database to compare in utero fetal and ex-utero preterm cerebellar growth trajectories.
These findings will inform specific targets, interventions and timing of future neuroprotective strategies, advance clinical practices and improve neurodevelopmental outcomes.
Premature birth is a major public health problem, associated with a personal, familial and societal burden of enormous proportions.
The potentially lifelong cognitive, learning and affective-behavioral consequences have become the major determinant of life quality in prematurity survivors, with up to 50 percent of very premature infants experiencing dysfunction in these domains by school age. Impaired cerebellar development has been recently implicated in this dysfunction.
The onset and underlying mechanisms and consequences of prematurity-related cerebellar developmental impairment (CDI) remain poorly understood, which in turn have complicated the search for potential therapeutic interventions. We have described a clinically important, previously under-recognized form of prematurity-related cerebellar parenchymal injury in up to 20 percent of extremely preterm infants. Recently, our observations have extended beyond the role of parenchymal cerebellar injury to a broader and more prevalent spectrum of cerebellar developmental impairments. We have shown that cerebellar development is markedly accelerated during the third trimester, but significantly impeded after premature birth, even in the absence of direct cerebellar injury. Complementing this intriguing set of structural observations are our findings of a distinctive long-term neuropsychological profile of cognitive, language, affective and social deficiency, which we have termed the developmental cerebellar cognitive affective disorder.
The onset and underlying mechanisms and consequences of prematurity-related CDI remain poorly understood, which in turn have complicated the search for potential therapeutic interventions. We propose to utilize serial, advanced MRI techniques to elucidate the timing, evolution, mechanisms and risk factors of CDI in preterm infants born ≤32 weeks gestational age. Our overarching goal is to identify early MR imaging biomarkers of prematurity-related CDI and the associated clinical factors that lead to specific development disabilities.